{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:05:12Z","timestamp":1772136312985,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"crossref","award":["GSA23C003"],"award-info":[{"award-number":["GSA23C003"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AFM-TELETHON","award":["AFM 23771"],"award-info":[{"award-number":["AFM 23771"]}]},{"name":"PRIN 2022 PNRR","award":["P2022LSW98"],"award-info":[{"award-number":["P2022LSW98"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The metabolic modulator trimetazidine (TMZ) is an antianginal recently found to improve skeletal muscle performance in mice models of sarcopenia and of amyotrophic lateral sclerosis (ALS). The mechanism underlying the effect of TMZ on locomotor activity has been proposed to rely on its ability to enhance metabolic efficiency with a consequent improvement of myogenesis and of neuromuscular junction (NMJ) and muscle function. However, although promising and therefore under clinical trials, the mechanism of action of TMZ has not been clearly disclosed; here we hypothesized that it might involve the modulation of neuronal Ca\n                    <jats:sup>2+<\/jats:sup>\n                    flows. We studied the effect of TMZ on Ca\n                    <jats:sup>2+<\/jats:sup>\n                    dynamics in vivo, by using the transgenic zebrafish line\n                    <jats:italic>Tg(neurod1<\/jats:italic>\n                    :GCaMP6f\n                    <jats:italic>)<\/jats:italic>\n                    in which the neuronal expression of the Ca\n                    <jats:sup>2+<\/jats:sup>\n                    indicator GCaMP allows to visualize Ca\n                    <jats:sup>2+<\/jats:sup>\n                    dynamics in neurons of zebrafish larvae. By this elegant tool, we demonstrated, for the first time, that TMZ promotes an increase of intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    transients in zebrafish spinal neurons likely enhancing motor neuron firing, which correlates with enhanced motor performance induced by this drug. Even though elevated intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    levels have often been associated to neurotoxicity, it is unclear if the neuronal excitability features in some neuro-muscular disorders are compensatory or pathological. Therefore, this newly reported effect of TMZ which transiently and selectively enhances spinal neuron firing deserves to be further detailed and taken into account when the possible repurposing of this drug is proposed for the treatment of neuro-muscular disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-06065-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:07:21Z","timestamp":1751404041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimetazidine stimulates intracellular Ca2+ transients and zebrafish locomotor activity in spinal neurons"],"prefix":"10.1038","volume":"15","author":[{"given":"Sara","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Gabellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"6065_CR1","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1152\/ajpendo.00083.2005","volume":"290","author":"LD Monti","year":"2006","unstructured":"Monti, L. D. et al. Metabolic and endothelial effects of Trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy. Am. J. Physiol. Endocrinol. Metab. 290, E54\u2013E59. https:\/\/doi.org\/10.1152\/ajpendo.00083.2005 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"6065_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jcsm.12097","volume":"7","author":"E Ferraro","year":"2016","unstructured":"Ferraro, E. et al. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J. Cachexia Sarcopenia Muscle. 7, 449\u2013457. https:\/\/doi.org\/10.1002\/jcsm.12097 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"6065_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/jcsm.12226","volume":"8","author":"F Molinari","year":"2017","unstructured":"Molinari, F. et al. The mitochondrial metabolic reprogramming agent Trimetazidine as an \u2018exercise mimetic\u2019 in cachectic C26-bearing mice. J. Cachexia Sarcopenia Muscle. 8, 954\u2013973. https:\/\/doi.org\/10.1002\/jcsm.12226 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"6065_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphys.2019.00897","volume":"10","author":"R Belli","year":"2019","unstructured":"Belli, R. et al. Metabolic Reprogramming Promotes Myogenesis Dur. Aging Front. Physiol. 10, 897. https:\/\/doi.org\/10.3389\/fphys.2019.00897. (2019).","journal-title":"Metabolic Reprogramming Promotes Myogenesis Dur. Aging Front. Physiol."},{"key":"6065_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.phrs.2011.01.003","volume":"63","author":"C Vitale","year":"2011","unstructured":"Vitale, C. et al. Trimetazidine improves exercise performance in patients with peripheral arterial disease. Pharmacol. Res. 63, 278\u2013283. https:\/\/doi.org\/10.1016\/j.phrs.2011.01.003 (2011).","journal-title":"Pharmacol. Res."},{"key":"6065_CR6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/bph.15738","volume":"179","author":"S Scaricamazza","year":"2022","unstructured":"Scaricamazza, S. et al. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1. Br. J. Pharmacol. 179, 1732\u20131752. https:\/\/doi.org\/10.1111\/bph.15738 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"6065_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s0303-8467(78)80013-4","volume":"80","author":"R Van den Bergh","year":"1977","unstructured":"Van den Bergh, R., Swerts, L., Hendrikx, A., Boni, L. & Meulepas, E. Adipose tissue cellularity in patients with amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. 80, 226\u2013239. https:\/\/doi.org\/10.1016\/s0303-8467(78)80013-4 (1977).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"6065_CR8","doi-asserted-by":"publisher","first-page":"117257","DOI":"10.1016\/j.jns.2020.117257","volume":"420","author":"P Fayemendy","year":"2021","unstructured":"Fayemendy, P. et al. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J. Neurol. Sci. 420, 117257. https:\/\/doi.org\/10.1016\/j.jns.2020.117257 (2021).","journal-title":"J. Neurol. Sci."},{"key":"6065_CR9","doi-asserted-by":"publisher","unstructured":"Ferri, A. & Coccurello, R. What is hyper in the ALS hypermetabolism? Mediat. Inflamm. 2017, 7821672. https:\/\/doi.org\/10.1155\/2017\/7821672 (2017).","DOI":"10.1155\/2017\/7821672"},{"key":"6065_CR10","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1016\/S0002-8703(03)00415-0","volume":"146","author":"G Fragasso","year":"2003","unstructured":"Fragasso, G. et al. Short- and long-term beneficial effects of Trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am. Heart J. 146, E18. https:\/\/doi.org\/10.1016\/S0002-8703(03)00415-0 (2003).","journal-title":"Am. Heart J."},{"key":"6065_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.res.86.5.580","volume":"86","author":"PF Kantor","year":"2000","unstructured":"Kantor, P. F., Lucien, A., Kozak, R. & Lopaschuk, G. D. The antianginal drug Trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 86, 580\u2013588. https:\/\/doi.org\/10.1161\/01.res.86.5.580 (2000).","journal-title":"Circ. Res."},{"key":"6065_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cmet.2018.07.016","volume":"28","author":"J Kalucka","year":"2018","unstructured":"Kalucka, J. et al. Quiescent endothelial cells upregulate fatty acid \u03b2-Oxidation for vasculoprotection via redox homeostasis. Cell. Metab. 28, 881\u2013894e813. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.016 (2018).","journal-title":"Cell. Metab."},{"key":"6065_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF00805569","volume":"92","author":"C Guarnieri","year":"1997","unstructured":"Guarnieri, C., Finelli, C., Zini, M. & Muscari, C. Effects of Trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria. Basic. Res. Cardiol. 92, 90\u201395. https:\/\/doi.org\/10.1007\/BF00805569 (1997).","journal-title":"Basic. Res. Cardiol."},{"key":"6065_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1113\/eph8802498","volume":"88","author":"CM Stary","year":"2003","unstructured":"Stary, C. M., Kohin, S., Samaja, M., Howlett, R. A. & Hogan, M. C. Trimetazidine reduces basal cytosolic Ca2\u2009+\u2009concentration during hypoxia in single Xenopus skeletal myocytes. Exp. Physiol. 88, 415\u2013421. https:\/\/doi.org\/10.1113\/eph8802498 (2003).","journal-title":"Exp. Physiol."},{"key":"6065_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cbi.2015.04.022","volume":"236","author":"J Wei","year":"2015","unstructured":"Wei, J., Xu, H., Shi, L., Tong, J. & Zhang, J. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis. Chem. Biol. Interact. 236, 47\u201356. https:\/\/doi.org\/10.1016\/j.cbi.2015.04.022 (2015).","journal-title":"Chem. Biol. Interact."},{"key":"6065_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/FJC.0000000000001434","volume":"82","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z. et al. Trimetazidine affects mitochondrial calcium uniporter expression to restore ischemic heart function via reactive oxygen Species\/NF\u03baB pathway Inhibition. J. Cardiovasc. Pharmacol. 82, 104\u2013116. https:\/\/doi.org\/10.1097\/FJC.0000000000001434 (2023).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"6065_CR17","doi-asserted-by":"publisher","first-page":"105138","DOI":"10.1016\/j.neubiorev.2023.105138","volume":"148","author":"NAS Oliveira","year":"2023","unstructured":"Oliveira, N. A. S., Pinho, B. R. & Oliveira, J. M. A. Swimming against ALS: how to model disease in zebrafish for pathophysiological and behavioral studies. Neurosci. Biobehav Rev. 148, 105138. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105138 (2023).","journal-title":"Neurosci. Biobehav Rev."},{"key":"6065_CR18","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s10072-024-07508-6","volume":"45","author":"GB Kubat","year":"2024","unstructured":"Kubat, G. B. & Picone, P. Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches. Neurol. Sci. 45, 4121\u20134131. https:\/\/doi.org\/10.1007\/s10072-024-07508-6 (2024).","journal-title":"Neurol. Sci."},{"key":"6065_CR19","doi-asserted-by":"publisher","unstructured":"Le Gall, L. et al. Molecular and cellular mechanisms affected in ALS. J. Pers. Med. 10 https:\/\/doi.org\/10.3390\/jpm10030101 (2020).","DOI":"10.3390\/jpm10030101"},{"issue":"Suppl 1","key":"6065_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/21678421.2013.778554","volume":"14","author":"MR Turner","year":"2013","unstructured":"Turner, M. R. et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 14 (Suppl 1), 19\u201332. https:\/\/doi.org\/10.3109\/21678421.2013.778554 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"6065_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland, L. P. & Shneider, N. A. Amyotrophic lateral sclerosis. N Engl. J. Med. 344, 1688\u20131700. https:\/\/doi.org\/10.1056\/NEJM200105313442207 (2001).","journal-title":"N Engl. J. Med."},{"key":"6065_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fnins.2020.00363","volume":"14","author":"A Brunet","year":"2020","unstructured":"Brunet, A., Stuart-Lopez, G., Burg, T., Scekic-Zahirovic, J. & Rouaux, C. Cortical circuit dysfunction as a potential driver of amyotrophic lateral sclerosis. Front. Neurosci. 14, 363. https:\/\/doi.org\/10.3389\/fnins.2020.00363 (2020).","journal-title":"Front. Neurosci."},{"key":"6065_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bpa.12350","volume":"26","author":"JP Loeffler","year":"2016","unstructured":"Loeffler, J. P., Picchiarelli, G., Dupuis, L. & Gonzalez De Aguilar, J. L. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 26, 227\u2013236. https:\/\/doi.org\/10.1111\/bpa.12350 (2016).","journal-title":"Brain Pathol."},{"key":"6065_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fncel.2015.00225","volume":"9","author":"SS Leal","year":"2015","unstructured":"Leal, S. S. & Gomes, C. M. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front. Cell. Neurosci. 9, 225. https:\/\/doi.org\/10.3389\/fncel.2015.00225 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"6065_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41598-021-04267-8","volume":"12","author":"G De Marco","year":"2022","unstructured":"De Marco, G. et al. Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis. Sci. Rep. 12, 395. https:\/\/doi.org\/10.1038\/s41598-021-04267-8 (2022).","journal-title":"Sci. Rep."},{"key":"6065_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","volume":"7","author":"BJ Wainger","year":"2014","unstructured":"Wainger, B. J. et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell. Rep. 7, 1\u201311. https:\/\/doi.org\/10.1016\/j.celrep.2014.03.019 (2014).","journal-title":"Cell. Rep."},{"key":"6065_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","volume":"37","author":"S Vucic","year":"2014","unstructured":"Vucic, S., Rothstein, J. D. & Kiernan, M. C. Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends Neurosci. 37, 433\u2013442. https:\/\/doi.org\/10.1016\/j.tins.2014.05.006 (2014).","journal-title":"Trends Neurosci."},{"key":"6065_CR28","doi-asserted-by":"publisher","unstructured":"Park, S. B., Kiernan, M. C. & Vucic, S. Axonal Excitability in Amyotrophic Lateral Sclerosis: Axonal Excitability in ALS. Neurotherapeutics 14, 78\u201390. (2017). https:\/\/doi.org\/10.1007\/s13311-016-0492-9","DOI":"10.1007\/s13311-016-0492-9"},{"key":"6065_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.expneurol.2015.09.019","volume":"275 Pt 1","author":"AE King","year":"2016","unstructured":"King, A. E., Woodhouse, A., Kirkcaldie, M. T. & Vickers, J. C. Excitotoxicity in ALS: overstimulation, or overreaction? Exp. Neurol. 275 Pt 1, 162\u2013171. https:\/\/doi.org\/10.1016\/j.expneurol.2015.09.019 (2016).","journal-title":"Exp. Neurol."},{"key":"6065_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/jnnp-2017-315574","volume":"88","author":"M de Carvalho","year":"2017","unstructured":"de Carvalho, M., Kiernan, M. C. & Swash, M. Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance. J. Neurol. Neurosurg. Psychiatry. 88, 773\u2013779. https:\/\/doi.org\/10.1136\/jnnp-2017-315574 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"6065_CR31","doi-asserted-by":"publisher","first-page":"113509","DOI":"10.1016\/j.celrep.2023.113509","volume":"42","author":"P Harley","year":"2023","unstructured":"Harley, P. et al. Aberrant axon initial segment plasticity and intrinsic excitability of ALS HiPSC motor neurons. Cell. Rep. 42, 113509. https:\/\/doi.org\/10.1016\/j.celrep.2023.113509 (2023).","journal-title":"Cell. Rep."},{"key":"6065_CR32","doi-asserted-by":"publisher","first-page":"24515","DOI":"10.1038\/srep24515","volume":"6","author":"L Benedetti","year":"2016","unstructured":"Benedetti, L. et al. INaP selective Inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model. Sci. Rep. 6, 24515. https:\/\/doi.org\/10.1038\/srep24515 (2016).","journal-title":"Sci. Rep."},{"key":"6065_CR33","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.1038\/ncomms6999","volume":"6","author":"AC Devlin","year":"2015","unstructured":"Devlin, A. C. et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun. 6, 5999. https:\/\/doi.org\/10.1038\/ncomms6999 (2015).","journal-title":"Nat. Commun."},{"key":"6065_CR34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232\u2013240. https:\/\/doi.org\/10.1016\/j.expneurol.2003.10.004 (2004).","journal-title":"Exp. Neurol."},{"key":"6065_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1113\/jphysiol.2013.265843","volume":"592","author":"N Delestr\u00e9e","year":"2014","unstructured":"Delestr\u00e9e, N. et al. Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. J. Physiol. 592, 1687\u20131703. https:\/\/doi.org\/10.1113\/jphysiol.2013.265843 (2014).","journal-title":"J. Physiol."},{"key":"6065_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuroscience.2021.01.039","volume":"463","author":"A Filipchuk","year":"2021","unstructured":"Filipchuk, A. et al. Early hypoexcitability in a subgroup of spinal motoneurons in superoxide dismutase 1 Transgenic mice, a model of amyotrophic lateral sclerosis. Neuroscience 463, 337\u2013353. https:\/\/doi.org\/10.1016\/j.neuroscience.2021.01.039 (2021).","journal-title":"Neuroscience"},{"key":"6065_CR37","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Silva, M. L. et al. Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife 7. https:\/\/doi.org\/10.7554\/eLife.30955 (2018).","DOI":"10.7554\/eLife.30955"},{"key":"6065_CR38","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1152\/jn.00482.2009","volume":"102","author":"A Pambo-Pambo","year":"2009","unstructured":"Pambo-Pambo, A., Durand, J. & Gueritaud, J. P. Early excitability changes in lumbar motoneurons of Transgenic SOD1G85R and SOD1G(93A-Low) mice. J. Neurophysiol. 102, 3627\u20133642. https:\/\/doi.org\/10.1152\/jn.00482.2009 (2009).","journal-title":"J. Neurophysiol."},{"key":"6065_CR39","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1113\/jphysiol.2010.200659","volume":"589","author":"KA Quinlan","year":"2011","unstructured":"Quinlan, K. A., Schuster, J. E., Fu, R., Siddique, T. & Heckman, C. J. Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 589, 2245\u20132260. https:\/\/doi.org\/10.1113\/jphysiol.2010.200659 (2011).","journal-title":"J. Physiol."},{"key":"6065_CR40","doi-asserted-by":"publisher","unstructured":"Leroy, F., d\u2019Incamps, L., Imhoff-Manuel, B. & Zytnicki, D. R.D. Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis. Elife 3. (2014). https:\/\/doi.org\/10.7554\/eLife.04046.","DOI":"10.7554\/eLife.04046"},{"key":"6065_CR41","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/jnnp-2012-304019","volume":"84","author":"S Vucic","year":"2013","unstructured":"Vucic, S., Ziemann, U., Eisen, A., Hallett, M. & Kiernan, M. C. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J. Neurol. Neurosurg. Psychiatry. 84, 1161\u20131170. https:\/\/doi.org\/10.1136\/jnnp-2012-304019 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"6065_CR42","doi-asserted-by":"publisher","first-page":"136039","DOI":"10.1016\/j.neulet.2021.136039","volume":"759","author":"S Vucic","year":"2021","unstructured":"Vucic, S., Pavey, N., Haidar, M., Turner, B. J. & Kiernan, M. C. Cortical hyperexcitability: diagnostic and pathogenic biomarker of ALS. Neurosci. Lett. 759, 136039. https:\/\/doi.org\/10.1016\/j.neulet.2021.136039 (2021).","journal-title":"Neurosci. Lett."},{"key":"6065_CR43","doi-asserted-by":"publisher","first-page":"104532","DOI":"10.1016\/j.nbd.2019.104532","volume":"130","author":"L Saba","year":"2019","unstructured":"Saba, L. et al. Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations. Neurobiol. Dis. 130, 104532. https:\/\/doi.org\/10.1016\/j.nbd.2019.104532 (2019).","journal-title":"Neurobiol. Dis."},{"key":"6065_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1113\/jphysiol.2004.074138","volume":"563","author":"JJ Kuo","year":"2005","unstructured":"Kuo, J. J., Siddique, T., Fu, R. & Heckman, C. J. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 563, 843\u2013854. https:\/\/doi.org\/10.1113\/jphysiol.2004.074138 (2005).","journal-title":"J. Physiol."},{"key":"6065_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2013.02.011","volume":"54","author":"E Martin","year":"2013","unstructured":"Martin, E., Cazenave, W., Cattaert, D. & Branchereau, P. Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 54, 116\u2013126. https:\/\/doi.org\/10.1016\/j.nbd.2013.02.011 (2013).","journal-title":"Neurobiol. Dis."},{"key":"6065_CR46","doi-asserted-by":"publisher","first-page":"208ra149","DOI":"10.1126\/scitranslmed.3007529","volume":"5","author":"D Sareen","year":"2013","unstructured":"Sareen, D. et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl Med. 5, 208ra149. https:\/\/doi.org\/10.1126\/scitranslmed.3007529 (2013).","journal-title":"Sci. Transl Med."},{"key":"6065_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton, A. E., Chi\u00f2, A. & Traynor, B. J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17\u201323. https:\/\/doi.org\/10.1038\/nn.3584 (2014).","journal-title":"Nat. Neurosci."},{"key":"6065_CR48","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/stem.2354","volume":"34","author":"M Naujock","year":"2016","unstructured":"Naujock, M. et al. 4-Aminopyridine induced activity rescues hypoexcitable motor neurons from amyotrophic lateral sclerosis Patient-Derived induced pluripotent stem cells. Stem Cells. 34, 1563\u20131575. https:\/\/doi.org\/10.1002\/stem.2354 (2016).","journal-title":"Stem Cells"},{"key":"6065_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nn.4273","volume":"19","author":"S Sances","year":"2016","unstructured":"Sances, S. et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 19, 542\u2013553. https:\/\/doi.org\/10.1038\/nn.4273 (2016).","journal-title":"Nat. Neurosci."},{"key":"6065_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","volume":"90","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD. Neuron 90, 521\u2013534. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.005 (2016).","journal-title":"Neuron"},{"key":"6065_CR51","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1113\/JP278117","volume":"597","author":"V Marchand-Pauvert","year":"2019","unstructured":"Marchand-Pauvert, V. et al. Absence of hyperexcitability of spinal motoneurons in patients with amyotrophic lateral sclerosis. J. Physiol. 597, 5445\u20135467. https:\/\/doi.org\/10.1113\/JP278117 (2019).","journal-title":"J. Physiol."},{"key":"6065_CR52","doi-asserted-by":"publisher","first-page":"8901","DOI":"10.1523\/JNEUROSCI.3090-16.2017","volume":"37","author":"E Tremblay","year":"2017","unstructured":"Tremblay, E., Martineau, \u00c9. & Robitaille, R. Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: when motor units matter. J. Neurosci. 37, 8901\u20138918. https:\/\/doi.org\/10.1523\/JNEUROSCI.3090-16.2017 (2017).","journal-title":"J. Neurosci."},{"key":"6065_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuron.2013.07.027","volume":"80","author":"S Saxena","year":"2013","unstructured":"Saxena, S. et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80, 80\u201396. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.027 (2013).","journal-title":"Neuron"},{"key":"6065_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/01677063.2016.1182526","volume":"30","author":"ME Hale","year":"2016","unstructured":"Hale, M. E., Katz, H. R., Peek, M. Y. & Fremont, R. T. Neural circuits that drive startle behavior, with a focus on the Mauthner cells and spiral fiber neurons of fishes. J. Neurogenet. 30, 89\u2013100. https:\/\/doi.org\/10.1080\/01677063.2016.1182526 (2016).","journal-title":"J. Neurogenet."},{"key":"6065_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/72936","volume":"3","author":"JD Jontes","year":"2000","unstructured":"Jontes, J. D., Buchanan, J. & Smith, S. J. Growth cone and dendrite dynamics in zebrafish embryos: early events in synaptogenesis imaged in vivo. Nat. Neurosci. 3, 231\u2013237. https:\/\/doi.org\/10.1038\/72936 (2000).","journal-title":"Nat. Neurosci."},{"key":"6065_CR56","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1364\/BOE.7.001656","volume":"7","author":"P Rupprecht","year":"2016","unstructured":"Rupprecht, P., Prendergast, A., Wyart, C. & Friedrich, R. W. Remote z-scanning with a macroscopic voice coil motor for fast 3D multiphoton laser scanning microscopy. Biomed. Opt. Express. 7, 1656\u20131671. https:\/\/doi.org\/10.1364\/BOE.7.001656 (2016).","journal-title":"Biomed. Opt. Express"},{"key":"6065_CR57","doi-asserted-by":"publisher","unstructured":"Della Vecchia, S. et al. Trehalose Treatment in Zebrafish Model of Lafora Disease. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23126874 (2022).","DOI":"10.3390\/ijms23126874"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06065-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:07:22Z","timestamp":1751404042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06065-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6065"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06065-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5803344\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were conducted with the ethical approval of the Italian Ministry of Health (approval n\u00b0 584\/2019-PR), in accordance with the European Union\u2019s Directive 2010\/63\/EU on the protection of animals used for scientific purposes, under the supervision of the University of Pisa Animal Care and Use Committee, and conformed to ARRIVE guidelines 2.0 to improve the reporting of research involving animals. The investigators declare that the principle of the \u201c3R\u201d (replace, reduce and refine) was carefully fulfilled.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"22854"}}